Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis Research Letter

   


Authors: Godara, A.; Toskic, D.; Albanese, J.; Rosenthal, B.; Siddiqui, N. S.; Kugelmass, A.; Zhou, P.; Fogaren, T.; Varga, C.; Landau, H. J.; Comenzo, R. L.
Title: Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis
Keywords: treatment outcome; treatment response; overall survival; follow up; letter; mass spectrometry; protein blood level; bortezomib; heart disease; kidney disease; maintenance therapy; melphalan; stem cell transplantation; prediction; sex ratio; minimal residual disease; peripheral blood stem cell; laboratory test; aging; therapy effect; sex difference; bone marrow cell; immunoglobulin light chain; protein electrophoresis; protein urine level; humoral immunity; hemodialysis; serology; troponin i; myeloma; multiple organ failure; amino terminal pro brain natriuretic peptide; al amyloidosis; human; priority journal; daratumumab; amyloid complete response; very good partial response
Journal Title: American Journal of Hematology
Volume: 96
Issue: 1
ISSN: 0361-8609
Publisher: John Wiley & Sons, Inc.  
Date Published: 2021-01-01
Start Page: E20
End Page: E23
Language: English
DOI: 10.1002/ajh.26025
PUBMED: 33068021
PROVIDER: scopus
PMCID: PMC8436337
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85096672856&doi=10.1002%2fajh.26025&partnerID=40&md5=8770342acec42fec8f25802acde7af48
Notes: Letter -- Export Date: 4 January 2021 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Heather Jolie Landau
    419 Landau
Related MSK Work